CCIA
IMCR icon

Campbell & Co Investment Adviser’s Immunocore IMCR Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,322
Closed -$476K – 1176
2024
Q1 		$476K Buy
+7,322
New +$502K 0.04% 718
2023
Q4 		– Sell
-7,965
Closed -$413K – 1199
2023
Q3 		$413K Sell
7,965
-675
-8% -$39.9K 0.05% 600
2023
Q2 		$518K Buy
+8,640
New +$493K 0.09% 423

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Campbell & Co Investment Adviser's IMCR Position: Q2 2024 in Review

Campbell & Co Investment Adviser sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 7,322 shares — an estimated $476K sold.

Campbell & Co Investment Adviser first reported a position in IMCR in Q2 2023 and held it in 3 quarters. The position peaked at $518K in Q2 2023. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Campbell & Co Investment Adviser reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 7,322 Immunocore shares in Q2 2024, an estimated $476K.
  • Campbell & Co Investment Adviser first reported a position in Immunocore in Q2 2023 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Immunocore position peaked at $518K in Q2 2023.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2024, filed 13 Aug 2024.